SCHEMBL13010983

SCHEMBL13010983

[2H]C([2H])([2H])OC(=C1C2CC3CC(C2)CC1C3)c1ccc(Cl)c(O[C@@H]2OC(CO)[C@@H](O)C(O)[C@@H]2O)c1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.41
SLC5A2 P31639 1/20 0.41
TYR P14679 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005853 1.00 ACHE (0.41) ACHESLC5A2TYR
SCHEMBL13005848 1.00 ACHE (0.41) ACHESLC5A2TYR
SCHEMBL13010974 1.00 ACHE (0.41) ACHESLC5A2TYR
SCHEMBL15147270 0.94 ACHE (0.44) ACHETYR
SCHEMBL15505419 0.89 ACHE (0.41) ACHESLC5A2TYR
SCHEMBL15144451 0.87 SNCA (0.37) ACHETYR
SCHEMBL10200779 0.83 ACHE (0.40) ACHETYR
SCHEMBL15144454 0.83 KDM4E (0.34) ACHE
SCHEMBL17030513 0.81 ACHE (0.39) ACHETYR
SCHEMBL17030495 0.81 SNCA (0.33) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546150-B2 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates Michigan Diagnostics, L.L.C. (US) 2013-10-01 US disclosed
US-20100317031-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ PAL 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317031-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, MPO ACHE 471/4885SLC5A2 3092/4885TYR 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.